|
Results and Accomplishments
Since 2003, the Pancreatic Cancer Action Network has awarded $12.7 million in research funds to 66 scientists at prestigious biomedical research institutions across the U.S.
Some of the scientific advances made possible with research funding from the Pancreatic Cancer Action Network include:
- Development of the first genetic mouse model of pancreatic cancer that accurately mimics human disease and progression, which has since been widely used in research laboratories around the world.
- Discovery and analysis of potential biomarkers (including plectin 1) that distinguish pancreatic cancer from normal cells or non-cancerous inflammation.
- Use of circulating tumor cells (cancer cells that are detectable in a patient’s bloodstream) to measure response to treatment, disease recurrence, or progression.
- Characterization of the genetic changes that take place within a cell to cause cancer.
- Enhanced understanding of the use of vaccines to stimulate a patient’s immune system to attack cancer cells.
 EVALUATION OF RESEARCH GRANTS PROGRAM
Each year, we thoroughly evaluate our research grants program to assess its effectiveness in building a comprehensive research community and moving the science toward a cure. Between 2003 and 2009, the Pancreatic Cancer Action Network invested approximately $4.8 million in research. Grant recipients successfully leveraged that investment into $41.7 million in subsequent research funding in order to continue take the next steps of their research endeavors and continue pursuing breakthroughs in pancreatic cancer research. Furthermore, this group of grantees has published 219 scientific articles, disseminating their research findings to the scientific community and moving the science forward. Learn more about our most recent evaluation, performed in early 2011.
|
Share This Site
